文献速递慢性肾脏病

晚期CKD患者蛋白尿与肾功能轨迹:CRIC与KNOW-CKD研究

Proteinuria and Kidney Function Trajectories in Patients with Advanced CKD: Insights from Chronic Renal Insufficiency Cohort and Korean Cohort Study for Outcome in Patients with CKD Studies.
PubMed 文献 · Clin J Am Soc Nephrol · 2026-08-27

该研究分析CRIC和KNOW-CKD队列中2727例eGFR 15-45 ml/min/1.73 m²且未行肾脏替代治疗的CKD患者,探讨基线及随时间更新的尿蛋白肌酐比(UPCR)与CKD进展的关系。结果显示UPCR越高,CKD进展风险越高、eGFR下降越快、达到肾衰竭eGFR阈值的时间越短,提示蛋白尿在晚期CKD中具有重要预后意义。

要点

  • 在CKD G3b-G4患者中,UPCR越高,肾功能快速下降风险越高。
  • 随时间更新的UPCR与CKD进展关联更强,持续低UPCR与低进展风险相关。
  • UPCR较低者肾功能下降更慢,达到肾衰竭eGFR阈值时间更长。

核心结论

  • 较高的UPCR与CKD加速进展及更短达到肾衰竭eGFR阈值时间强烈相关,凸显蛋白尿在晚期CKD中的预后意义。

研究设计与样本

  • 研究分析CRIC和KNOW-CKD研究中2727例eGFR 15-45 ml/min/1.73 m²且未行KRT的参与者,暴露为基线和随时间更新的UPCR。
  • 主要结局为CKD进展,定义为eGFR较基线下降≥50%或启动KRT;次要结局为eGFR斜率;探索性结局为达到肾衰竭eGFR阈值10 ml/min/1.73 m²的预计时间。

主要发现

  • 中位随访4.9年(共17069人年),1474例(54%)发生主要结局。
  • 与UPCR<0.5 g/gCr相比,UPCR 0.5-1.0、1.0-3.0和≥3.0 g/gCr的HR(95%CI)分别为2.08(1.76-2.45)、3.05(2.64-3.52)和6.32(5.24-7.61)。
  • 随时间更新UPCR分析中关联更强,对应HR(95%CI)分别为2.58(2.13-3.12)、5.61(4.76-6.62)和12.88(10.58-15.67)。
  • 各UPCR分类的eGFR斜率分别为-0.87(-0.98至-0.77)、-2.32(-2.56至-2.07)、-3.41(-3.63至-3.19)和-5.45(-5.93至-4.97)ml/min/1.73 m²/年。
  • 达到肾衰竭eGFR阈值的预计时间(95%CI)随蛋白尿分类升高而缩短,分别为28.7(25.6-32.6)、10.3(9.3-11.5)、6.4(6.0-6.8)和3.8(3.5-4.2)年。

关键数值与推荐

  • UPCR分类界值:<0.5、0.5-1.0、1.0-3.0、≥3.0 g/gCr。
  • CKD进展定义:eGFR较基线下降≥50%或启动KRT。
  • 肾衰竭eGFR阈值为10 ml/min/1.73 m²。

临床怎么用

  • 在晚期CKD(G3b-G4)患者中,应重视UPCR监测,持续低UPCR与较低进展风险相关。
  • UPCR较高者肾功能下降更快、达到肾衰竭eGFR阈值时间更短,可辅助风险分层与随访规划。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Higher urine protein-to-creatinine ratios were strongly associated with a rapid decline in kidney function in patients with CKD stages G3b-G4. The stronger association observed with time-updated urine protein-to-creatinine ratio suggests that sustained lower urine protein-to-creatinine ratio was associated with lower risk of CKD progression. In advanced CKD, patients with lower proteinuria levels exhibited slower kidney function decline and longer time to eGFR threshold for kidney failure. BACKGROUND: Although urine protein-to-creatinine ratio (UPCR) is more commonly used than urine albumin-to-creatinine ratio in routine care, and particularly in low-resource settings, its association with kidney function decline and projected time to reach a kidney failure eGFR threshold in advanced CKD remains underexplored. METHODS: We analyzed 2727 participants with eGFR 15-45 ml/min per 1.73 m 2 without KRT from the Chronic Renal Insufficiency Cohort study and the Korean Cohort Study for Outcome in Patients with CKD (KNOW-CKD). The main exposures were baseline and time-updated UPCR. The primary outcome was CKD progression defined as 50% or more decline in eGFR from baseline measurement or the initiation of KRT. The secondary outcome was eGFR slope (ml/min per 1.73 m 2 per year), whereas the exploratory outcome was projected time to reach the eGFR threshold of 10 ml/min per 1.73 m 2 for kidney failure. RESULTS: During 17,069 person-years of follow-up (median 4.9 years), the primary outcome occurred in 1474 participants (54%). Compared with UPCR <0.5 g/gCr, hazard ratios (95% confidence intervals [CIs]) for UPCR categories of 0.5-1.0, 1.0-3.0, and ≥3.0 g/gCr were 2.08 (1.76 to 2.45), 3.05 (2.64 to 3.52), and 6.32 (5.24 to 7.61), respectively. This association was stronger in analysis with time-updated UPCR, with the corresponding hazard ratios (95% CIs) of 2.58 (2.13 to 3.12), 5.61 (4.76 to 6.62), and 12.88 (10.58 to 15.67), respectively. In secondary analyses, the eGFR slopes for the respective categories were -0.87 (-0.98 to -0.77), -2.32 (-2.56 to -2.07), -3.41 (-3.63 to -3.19), and -5.45 (-5.93 to -4.97) ml/min per 1.73 m 2 per year. In addition, projected time to eGFR threshold for kidney failure (95% CIs) was lower progressively with increasing proteinuria categories, estimated at 28.7 (25.6 to 32.6), 10.3 (9.3 to 11.5), 6.4 (6.0 to 6.8), and 3.8 (3.5 to 4.2) years, respectively. CONCLUSIONS: Higher UPCRs were strongly associated with accelerated CKD progression and shorter projected time to reach the eGFR threshold for kidney failure, underscoring the prognostic significance of proteinuria in patients with advanced CKD.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Park CH, Hong HJ, Kim HW, et al. Proteinuria and Kidney Function Trajectories in Patients with Advanced CKD: Insights from Chronic Renal Insufficiency Cohort and Korean Cohort Study for Outcome in Patients with CKD Studies. Clin J Am Soc Nephrol. 2026. PMID: 42658641. doi:10.2215/CJN.0000001206

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。